References
1. Van Hemelrijck M., Taramasso M., De Carlo C., Kuwata S., Regar E., Nietlispach F., et al. Recent advances in understanding and managing aortic stenosis. F1000Res. 2018; 7: 58. DOI: https://doi.org/10.12688/f1000research.11906.1
2. Iung B., Delgado V., Rosenhek R., Price S., Prendergast B., Wendler O., et al.; EORP VHD II Investigators. Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II Survey. Circulation 2019; 140: 1156–69.
3. Dahl J.S., Eleid M.F., Michelena H.I., Scott C.G., Suri R.M., et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging. 2015; 8: e002917.
4. Taniguchi T., Morimoto T., Shiomi H., Ando K., Kanamori N., Murata K., et al.; CURRENT AS Registry Investigators. Prognostic impact of left ventricular ejection fraction in patients with severe aortic stenosis. JACC Cardiovasc Interv. 2018; 11: 145–7.
5. Leon M.B., Smith C.R., Mack M., Miller D.C., Moses J.W., Svensson L.G., et al.; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363 (17): 1597–607. DOI: https://doi.org/10.1056/NEJMoa1008232
6. Smith C.R., Leon M.B., Mack M.J., Miller D.C., Moses J.W., Svensson L.G., et al.; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364 (23): 2187–98. DOI: https://doi.org/10.1056/NEJMoa1103510
7. Adams D.H., Popma J.J., Reardon M.J., Yakubov S.J., Coselli J.S., Deeb G.M., et al.; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014; 370 (19): 1790–8. DOI: https://doi.org/10.1056/NEJMoa1400590
8. Thyregod H.G., Steinbrüchel D.A., Ihlemann N., Nissen H., Kjeldsen B.J., Petursson P., et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015; 65 (20): 2184–94. DOI: https://doi.org/10.1016/j.jacc.2015.03.014 Epub 2015 Mar 15.
9. Faggiano P., Antonini-Canterin F., Baldessin F., Lorusso R., D’Aloia A., Cas L.D. Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovasc Ultrasound. 2006; 4: 27. DOI: https://doi.org/10.1186/1476-7120-4-27
10. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013; 127 (1): e6–245. DOI: https://doi.org/10.1161/CIR.0b013e31828124ad Epub 2012 Dec 12.
11. Thaden J.J., Nkomo V.T., Enriquez-Sarano M. The global burden of aortic stenosis. Prog Cardiovasc Dis. 2014; 56 (6): 565–71. DOI: https://doi.org/10.1016/j.pcad.2014.02.006
12. Ahn C.B., Lee S.I., Choi C.H., Park C.H., Park K.Y., Lee J.W., et al. Feasibility of a 3D printed patient-specific model system to determine hemodynamic energy delivery during extracorporeal circulation. ASAIO J. 2018; 64 (3): 309–17. DOI: https://doi.org/10.1097/MAT.0000000000000638
13. Giannopoulos A.A., Steigner M.L., George E., Barile M., Hunsaker A.R., Rybicki F.J., et al. Cardiothoracic applications of 3-dimensional printing. J Thorac Imaging. 2016; 31 (5): 253–72. DOI: https://doi.org/10.1097/RTI.0000000000000217
14. Lim H.G., Jeong S., Kim G.B., Lee W., Son K.H., Kim Y.J. Next-generation transcatheter aortic valve implantation. JTCVS Open. 2020; 3: 14–24. DOI: https://doi.org/10.1016/j.xjon.2020.06.008 PMID: 36003870; PMCID: PMC9390526.
15. Farooqi K.M., Mahmood F. Innovations in Preoperative Planning: Insights into Another Dimension Using 3D Printing for Cardiac Disease. J Cardiothorac Vasc Anesth. 2018; 32 (4): 1937-1945. DOI: 10.1053/j.jvca.2017.11.037
16. Thourani V.H., Suri R.M., Gunter R.L., Sheng S., O’Brien S.M., Ailawadi G., et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. Ann Thorac Surg. 2015; 99 (1): 55–61.
17. Gleason T.G., Reardon M.J., Popma J.J., Deeb G.M., Yakubov S.J., Lee J.S., et al.; CoreValve US Pivotal High Risk Trial Clinical Investigators. 5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol. 2018; 72 (22): 2687–96.